{"title":"Highlights from the 17th Japan Bioanalysis Forum Symposium.","authors":"Katsutomo Hata, Naohito Yamada, Hiroyuki Shimizu, Tomoko Arakawa, Hitoshi Uchiyama, Miyuki Ugajin, Takeshi Okuzono, Eiichi Shimada, Masanori Nagata, Masayo Hashimoto, Hisanori Hara, Takashi Miyayama, Tamiki Mori, Ken-Ichi Yamamoto","doi":"10.1080/17576180.2026.2712772","DOIUrl":null,"url":null,"abstract":"<p><p>The 17th Japan Bioanalysis Forum Symposium was held in Himeji, Japan, in March 2026. Under the theme \"Unlock Scientific Potential: Future of Bioanalytical Expert,\" the symposium provided a comprehensive forum to share and discuss the latest scientific, technological, and regulatory developments in bioanalysis essential for drug development.The scientific program comprised 12 sessions including 35 oral presentations and 2 panel discussions, 38 general poster presentations, and 12 discussion group poster sessions. The topics spanned a broad range of disciplines, including implementation of ICH M10 and data integrity requirements, bioanalysis of oligonucleotides, gene and cell therapies, antibody-drug conjugates, immunogenicity assessment, biomarker analysis, and advances in LC-MS/MS and ligand‑binding assays. In addition, emerging trends such as artificial intelligence and automation in bioanalytical workflows were actively discussed. The newly introduced sessions for junior bioanalysts and Casual Follow-Up Sessions fostered open dialogue and received particularly strong engagement from the participants. The poster sessions by the individuals and by the discussion groups facilitated lively scientific exchange, further enhanced by the record number of company exhibits. Overall, the symposium successfully highlighted the current challenges and future directions in bioanalysis, reinforcing the critical role of bioanalytical experts in advancing drug development and regulatory science.</p>","PeriodicalId":8797,"journal":{"name":"Bioanalysis","volume":" ","pages":"947-954"},"PeriodicalIF":2.1000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13540187/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioanalysis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17576180.2026.2712772","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/11 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
The 17th Japan Bioanalysis Forum Symposium was held in Himeji, Japan, in March 2026. Under the theme "Unlock Scientific Potential: Future of Bioanalytical Expert," the symposium provided a comprehensive forum to share and discuss the latest scientific, technological, and regulatory developments in bioanalysis essential for drug development.The scientific program comprised 12 sessions including 35 oral presentations and 2 panel discussions, 38 general poster presentations, and 12 discussion group poster sessions. The topics spanned a broad range of disciplines, including implementation of ICH M10 and data integrity requirements, bioanalysis of oligonucleotides, gene and cell therapies, antibody-drug conjugates, immunogenicity assessment, biomarker analysis, and advances in LC-MS/MS and ligand‑binding assays. In addition, emerging trends such as artificial intelligence and automation in bioanalytical workflows were actively discussed. The newly introduced sessions for junior bioanalysts and Casual Follow-Up Sessions fostered open dialogue and received particularly strong engagement from the participants. The poster sessions by the individuals and by the discussion groups facilitated lively scientific exchange, further enhanced by the record number of company exhibits. Overall, the symposium successfully highlighted the current challenges and future directions in bioanalysis, reinforcing the critical role of bioanalytical experts in advancing drug development and regulatory science.
BioanalysisBIOCHEMICAL RESEARCH METHODS-CHEMISTRY, ANALYTICAL
CiteScore
3.30
自引率
16.70%
发文量
88
审稿时长
2 months
期刊介绍:
Reliable data obtained from selective, sensitive and reproducible analysis of xenobiotics and biotics in biological samples is a fundamental and crucial part of every successful drug development program. The same principles can also apply to many other areas of research such as forensic science, toxicology and sports doping testing.
The bioanalytical field incorporates sophisticated techniques linking sample preparation and advanced separations with MS and NMR detection systems, automation and robotics. Standards set by regulatory bodies regarding method development and validation increasingly define the boundaries between speed and quality.
Bioanalysis is a progressive discipline for which the future holds many exciting opportunities to further reduce sample volumes, analysis cost and environmental impact, as well as to improve sensitivity, specificity, accuracy, efficiency, assay throughput, data quality, data handling and processing.
The journal Bioanalysis focuses on the techniques and methods used for the detection or quantitative study of analytes in human or animal biological samples. Bioanalysis encourages the submission of articles describing forward-looking applications, including biosensors, microfluidics, miniaturized analytical devices, and new hyphenated and multi-dimensional techniques.
Bioanalysis delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for the modern bioanalyst.